Аннотация:
This study analyzed the use of a prolonged injection of naltrexone hydrochloride in the anti-relapse treatment of 148 patients with alcohol, opioid, or their combined use syndrome, with concomitant HIV infection. It is concluded that the effectiveness of treatment of HIV-infected patients with opioid and alcohol dependence syndromes is lower than in studies conducted on samples of drug-addicted patients without HIV infection. It is necessary to change the approach to the treatment of such a complex category of patients with the involvement of specialists from various fields of medicine and representatives of social services and therapeutic communities.
Ключевые слова:
sustained release naltrexone injection, alcohol addiction syndrome, opioid addiction syndrome, HIV infection.